Retail pharmacies (CVS, Walgreens) are still the largest channel — you walk in, show a prescription, and get your insulin or metformin. But online pharmacies are the fastest‑growing. The diabetes drug market research study shows that online pharmacies are growing at over 8% CAGR, driven by convenience, privacy, and price. Why? Because diabetics need refills every month, and home delivery saves trips to the pharmacy.

What's driving online adoption? Subscription models (auto‑refills), lower prices (20‑30% off retail), and the ability to compare prices across sellers. The diabetes drug market trends highlight that the fastest‑growing drug class online is GLP‑1s, because patients want discreet delivery of expensive injectables.

But online pharmacies have risks: counterfeit insulin (deadly), improper cold‑chain shipping, and delayed deliveries. That's why you should only buy from verified, licensed platforms.

The bottom line: online is convenient and cheaper, but be vigilant. And never buy insulin from an unverified source — your life depends on it.